In an unparalleled moment of technological advancement, as the growing prowess of AI becomes unignorable and researchers break new barriers every week in the treatment of cancer, Alzheimer’
As the healthcare industry emerges at last from the COVID-19 pandemic into a new, digitally supercharged world, stakeholders across the industry must move fast to embrace digital transforma
With new phase 3 data in hand, Boehringer Ingelheim is preparing to file for approval of nerandolimast, a would-be successor to its blockbuster idiopathic pulmonary fibrosis (IPF) therapy O
The Life Sciences Generative AI Council aims to bring together the best minds in pharma, academia, and technology to advance the use of GenAI in life sciences R&D, seeking through pinpo